<qa>  What is the first proof of concept study for OC000459?This is the first proof of concept study for OC000459 and is undertaken to assess the effects of the compound on the development of inflammatory cytokines in a model nasal allergen challenge model that is validated and clinically safe and easy to conduct. OC000459 will be compared with placebo in the study. 